维普中文期刊产品整合服务
21篇 您的检索式:作者名="Cheymol G"
    题名 作者 年代 出处 被引量
1Effects of obesity on pharmacokinetics implications for drug therapy显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
2Cyclosporine in whole blood drug monitoring difficulities and presentation of a reliable normal phase liquid chromatographic assay显示文摘Poirier JM Lebot JM Cheymol G 1994Ther Drug Monit1994,16,4:1
3Effects of obesity on pharmacokinetics implications for drug therapy显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
4Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects 显示文摘Cheymol G Woestenborghs R Snoeck E 1997Eur J Clin Pharmacol1997,5,6:1
5Effects of obesity on pharmacokinetics implica- tion for drug therapy 显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
6Effects of obesity on pharmacokinetics implications for drug therapy显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
7Cyclosporine in whole blood: Drug monitoring difficulities and presentation of an normal phase liquid chromatographic assay 显示文摘POIRIER J M LEBOT J M CHEYMOL G 1994Ther Drug Monit1994,16,:1
8Effects of obesity on pharmacokineties implieations for drug therapy 显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
9Effects of obesity on pharma wkinetics implications for drug the rapy显示文摘Cheymol G 2000Clin Pharma cokinet2000,39,:1
10Clinical pharmacokinetics of drugs in obesity显示文摘Cheymol G 1993Chin Phamacokinet1993,25,2:1
11Recent aspect of monitoring the dosage of a minoglycosides and vancomycin显示文摘Cheymol G Poirier JM 1998Bull Acad Natl Med1998,182,2:1
12Effects of obesity on pharmacokinetics implications for drug therapy显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
13Effects of obesity on pharmacokinetics implications for drug therapy 显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
14Effects of obesity on pharmacokinetics:implications for drug therapy显示文摘CHEYMOL G 2000Clin Pharmacokinet2000,39,3:1
15Effects of obesity on pharmacokinetics implications for drug therapy显示文摘Cheymol G 2000Clin Pharmacokinet2000,39,3:1
16Optimisation of itraconazole therapy using target drug concentrations显示文摘Poirier J M Cheymol G 1998Clin Pharmacokinet1998,35,:1
17Effects of obesity on pharmacokinetics im- plications for drug therapy 显示文摘CHEYMOL G 2000Clin Pharmacokinet2000,39,3:1
18Cyclosporine in whole blood: drug monitoring difficulties and presentation of a reliable normal-phase liquid chromatographic assay 显示文摘Poirier JM Lebot M Cheymol G 1994Ther Drug Monit1994,16,4:1
19Cyclosporine in whole blood:Drug monitering difficulties and presentation of a reliable normal-phase liquid chromatographic assay显示文摘POIRIER JM LEBOT M CHEYMOL G 1994Thera Drug Monit1994,16,4:1
20Effects of obesity on pharmacokinetics:implications for drug therapy显示文摘Cheymol G 0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费